How ICER Misses What Matters

Update: 2020-02-20

Description

Gunnar Esiason, a cystic fibrosis advocate, explains why the Institute for Clinical and Economic Review’s model for determining drugs' value doesn't sit well with patients.

Comments

In Channel

Insurance Denials Leave Infants Unprotected

2020-06-0417:21

The Real Story on Gout

2020-05-1518:08

Tardive Dyskinesia Patients’ New Resource

2020-04-2908:31

How Insurers Hold Headache Patients Back

2020-04-1709:43

Moms, Don't Underestimate the Benefits of Seafood

2020-03-2616:08

America's Heart Disease Crisis

2020-03-1211:28

How ICER Misses What Matters

2020-02-2024:09

When Two is Better than One

2019-12-2010:47

The Cancer Care Struggle

2019-11-2112:58

Coming Soon: Out-of-Pocket Relief

2019-10-3010:05

What Nurses are Fighting For

2019-10-0415:17

What is Grateful Patient Day?

2019-08-2822:38

Who Cares about Patient Advocacy?

2019-08-1914:59

Hard to Swallow

2019-05-2215:22

The Benefits—and Hidden Costs—of Clinical Trials

2019-05-0808:30

Sick, Sad & Switched

2019-04-2616:49

Who’s Driving Insulin Prices?

2019-04-1112:32

This is Not Parkinson’s

2019-03-1313:18

Gout: Beyond the Myths

2019-02-1315:38

The Really Serious Virus

2019-01-2815:36

00:00

How ICER Misses What Matters

#box-pro-ellipsis-176239425600247{-webkit-line-clamp:2;}How ICER Misses What Matters

How ICER Misses What Matters

How ICER Misses What Matters